Table 2. The association of STAT3 expression and the survival in cancer patients.
| Cancer type | Dataset | Endpoint | Probe id | N | Cox p-value | Hr |
|---|---|---|---|---|---|---|
| Blood | GSE12417-GPL97 | Overall Survival | 243213_at | 163 | 0.000744 | 1.69 |
| Brain | GSE4271-GPL97 | Overall Survival | 243213_at | 77 | 0.047646 | 1.91 |
| Breast | GSE3143 | Overall Survival | 39708_at | 158 | 0.031082 | 0.47 |
| GSE7849 | Disease Free Survival | 39708_at | 76 | 0.017328 | 4.53 | |
| GSE7849 | Disease Free Survival | 289_at | 76 | 0.014144 | 4.92 | |
| GSE12276 | Relapse Free Survival | 208991_at | 204 | 0.067027 | 0.75 | |
| GSE6532-GPL570 | Relapse Free Survival | 208991_at | 87 | 0.015187 | 0.54 | |
| GSE6532-GPL570 | Distant Metastasis Free Survival | 208992_s_at | 87 | 0.012369 | 0.49 | |
| GSE6532-GPL570 | Distant Metastasis Free Survival | 208991_at | 87 | 0.015187 | 0.54 | |
| GSE6532-GPL570 | Relapse Free Survival | 225289_at | 87 | 0.046274 | 0.52 | |
| GSE6532-GPL570 | Distant Metastasis Free Survival | 225289_at | 87 | 0.046274 | 0.52 | |
| GSE6532-GPL570 | Relapse Free Survival | 208992_s_at | 87 | 0.012369 | 0.49 | |
| GSE9195 | Relapse Free Survival | 208991_at | 77 | 0.021717 | 3.80 | |
| GSE9195 | Relapse Free Survival | 243213_at | 77 | 0.018195 | 8.75 | |
| GSE9195 | Distant Metastasis Free Survival | 243213_at | 77 | 0.035491 | 9.33 | |
| GSE12093 | Distant Metastasis Free Survival | 208992_s_at | 136 | 0.016456 | 0.59 | |
| GSE12093 | Distant Metastasis Free Survival | 208991_at | 136 | 0.005146 | 0.27 | |
| GSE11121 | Distant Metastasis Free Survival | 208992_s_at | 200 | 0.020347 | 0.44 | |
| GSE9893 | Overall Survival | 21668 | 155 | 0.017780 | 0.69 | |
| GSE2034 | Distant Metastasis Free Survival | 208992_s_at | 286 | 0.015785 | 0.78 | |
| GSE2034 | Distant Metastasis Free Survival | 208991_at | 286 | 0.003215 | 0.53 | |
| GSE2990 | Relapse Free Survival | 208991_at | 62 | 0.037864 | 0.55 | |
| GSE2990 | Relapse Free Survival | 208992_s_at | 62 | 0.010824 | 0.33 | |
| Colorectal | GSE17537 | Disease Free Survival | 225289_at | 55 | 0.027763 | 0.21 |
| Eye | GSE22138 | Distant Metastasis Free Survival | 208992_s_at | 63 | 0.005425 | 2.00 |
| GSE22138 | Distant Metastasis Free Survival | 208991_at | 63 | 0.035231 | 1.66 | |
| Lung | GSE31210 | Relapse Free Survival | 208992_s_at | 204 | 0.001112 | 4.53 |
| GSE31210 | Relapse Free Survival | 225289_at | 204 | 0.017076 | 4.72 | |
| GSE31210 | Relapse Free Survival | 243213_at | 204 | 0.034308 | 0.54 | |
| GSE31210 | Overall Survival | 208992_s_at | 204 | 0.047705 | 3.43 | |
| GSE8894 | Relapse Free Survival | 243213_at | 138 | 0.002854 | 0.02 | |
| Ovarian | GSE9891 | Overall Survival | 208991_at | 278 | 0.049049 | 0.74 |
| Skin | GSE19234 | Overall Survival | 208991_at | 38 | 0.008049 | 0.20 |